TrialPsychopharmacology2012

Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder.

Robert Riesenberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.